Nine Point Two Capital LLC Bausch Health Companies Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 31,255 shares of BHC stock, worth $230,974. This represents 0.1% of its overall portfolio holdings.
Number of Shares
31,255
Previous 31,255
-0.0%
Holding current value
$230,974
Previous $256,000
2.34%
% of portfolio
0.1%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$257 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$217 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$195 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$116 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$96.1 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.67B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...